Medicine Information

Affordable Drugs: Saving Money by Splitting Pills


One of the least appreciated cost-savers in medical treatment is the simple act of splitting pills. Suppose you're a U.S. citizen with depression who needs to take Lexapro brand of escitalopram oxalate, a commonly prescribed antidepressant, at a typical starting dose of 10 milligrams (mg) per day. Let's figure out how much your treatment will cost, both by month and by day.

For purposes of illustration I'll use prices shown online at drugstore.com. If you buy thirty Lexapro 10-mg tablets (which is how the prescription is usually written) it will cost you $70.15 per month or $2.34 per day to get treated. But what if you buy Lexapro 20-mg tablets and take a half-pill each day? Medically, this treatment is the same. But look what happens to unit prices. Thirty Lexapro 20-mg tablets cost $69.99. We need just 10 mg per day, so we split the 20-mg tablets in half to make our 10-mg doses. (The tablets are even scored to make this easy.) In this case it costs you just $35.00 per month or $1.17 per day to get treated. Your daily price just dropped by half!

Isn't that amazing? And it's not just an isolated example. If you do a similar analysis for many other drugs, you'll find that taking half of a double-strength pill costs substantially less than taking all of a regular-strength pill. Or another way of saying this is that the cost of a month's treatment is driven more by the number of pills involved than by the total number of milligrams taken.

Is this an accident of pricing? Should we be whispering about this? Is this pulling something over on the drug companies? Hardly. If you think that multi-billion-dollar companies trading on the New York Stock Exchange make pricing mistakes, then I've got some choice swamp-land in Florida I'd love to sell you.

So why would drug companies create these pricing mismatches (read: opportunities)? To understand this, let's walk through two prescribing scenarios. First, suppose a doctor is prescribing Lexapro to a patient who is lucky enough to have drug insurance. The patient pays a predetermined co-payment for each month's worth of medication, so he or she has the exact same out-of-pocket expense whichever way the prescription is written. So will the doctor write for thirty 10-mg pills or fifteen 20-mg pills?

Your guess is probably right-the prescription will be written for the larger number of lower-strength pills. The retailer and the drug company will get full price. They're happy. The patient doesn't need to break tablets in half and the doctor doesn't need to take time to explain why pills have to be broken, so they're happy. What's not to like? The only loser is the insurance company. Do the doctor or the patient care? (Let's see, how many favors has the insurance company done for the doctor and patient lately?)

Now here's the second prescribing scenario. Joe Workingman has no drug insurance and has to shell out cash to pay for the full price of medication. The doctor feels that 10 mg daily of Lexapro is needed. This time, the doctor prescribes fifteen Lexapro 20-mg pills per month, instructing the patient to take a half-pill per day. Medically, there is no loss of efficacy. The patient is pleased to pay less money. The doctor is a hero for being thoughtful and clever. Because the doctor still prescribed the same product, the drug company is happy. (The drug company would rather get half their price than nothing. Besides, they've already priced this scenario into their drug.)

So the drug company wins either way, particularly if they're competing against a similar product made by another company that the doctor might choose instead. In fact, all it takes for everyone to be happy is a breakable tablet. Admittedly, some pills are difficult to break in half (but not excessively difficult, or else the drug company wouldn't capture the low-end market). This is where pill-cutters come in handy. Every drugstore has them. They're cheap because they're made out of nothing more than plastic and razor blades. They're better at splitting pills than your thumbs or a paring-knife because they break pills more evenly, and the pieces don't go skittering across the counter.

In the author's practice there are some pill-splitting overachievers who even manage to break quadruple-strength pills into quarters. Imagine the savings in doing that.

In fact, the only obstacle to saving the patient money is if the drug company puts their product into capsules, because capsules can't be split. Would a drug company do such a mean-spirited thing? You betcha.

Lexapro was the sixth so-called serotonin-reuptake-blocker to come on the market, so it had to compete with all the earlier drugs in its class. But the first serotonin-reuptake-blocker to come on the market had first-mover advantage and was able to retain market-share even after the competing products arrived. This first-mover was the world-famous Prozac brand of fluoxetine, made by the Eli Lilly Company.

So what did Lilly do after competing products appeared? They stone-walled the consumer by never ever putting their product into anything other than a capsule. Moreover, for the entire time their product was still patent-protected, they never produced a higher-strength capsule. So if you needed a higher dose of Prozac, you had the honor of paying for two or three capsules per day. Why did they choose such a consumer-unfriendly approach? Because they could. (Everyone now turn toward Indianapolis and wave to the nice people at Lilly.)

My medical students look at me strangely when I start talking about publicly traded companies and market forces while I'm supposed to be teaching them about medicine. But the way I look at it, if you don't understand market forces, then you'll never understand why things in medicine are the way they are.

(C) 2005 by Gary Cordingley

Gary Cordingley, MD, PhD, is a clinical neurologist, teacher and researcher who works in Athens, Ohio. For more health-related articles see his website at: http://www.cordingleyneurology.com


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Indianapolis Star

IU center for regenerative medicine will use body's own cells to treat woes of diabetes
Indianapolis Star
In a process that sounds straight out of science fiction, The Indiana Center for Regenerative Medicine and Engineering will focus on research into ways to take your body's existing cells and reprogram them with an eye toward healing. The medical school ...
IU School of Medicine to spend $20M to launch regenerative medicine centerIndianapolis Business Journal
IU Center to Focus on Regenerative MedicineInside INdiana Business

all 3 news articles »


Wall Street Journal

It's Early Days for the Use of AI in Medicine
Wall Street Journal
We disagree with your suggestion in “IBM Has a Watson Dilemma” (Exchange, Aug. 11) that IBM has not made enough progress on bringing the benefits of artificial intelligence to health care. It is true that IBM has placed a big bet on health care. We ...

and more »


WVU Medicine trauma surgeons use life-saving device on victim of motorcycle accident
WVU Medicine (press release)
MORGANTOWN, W.Va. – Surgeons at the Jon Michael Moore Trauma Center at WVU Medicine had a recent success with their first use of a resuscitative endovascular balloon occlusion of the aorta (REBOA) device to stop hemorrhaging in the victim of a ...



Flexible drug delivery microdevice to advance precision medicine ...
Science Daily
A research team has developed a flexible drug delivery device with controlled release for personalized medicine, blazing the path toward theragnosis.

and more »


KRVS

Medicine Ball Caravan: August 15, 2018
KRVS
Celebrating the 49th anniversary of the kick-off to the Woodstock Music & Arts Festival in Bethel, New York back in 1969 on Wednesday's MEDICINE BALL CARAVAN on KRVS (11am-noon Central Standard on 88.7FM locally or at krvs.org).



NBC 5 Dallas-Fort Worth

New Migraine Medicine Relieves Pain For North Texas Doctor
NBC 5 Dallas-Fort Worth
More than 38,000 Americans suffer from migraines, according to the Migraine Research Foundation. There hasn't been a medicine specifically designed to treat migraines up until this summer. In May, the FDA approved erenumab (Aimovig), the first ...

and more »


Is your thyroid medicine hurting your heart? - wistv.com - Columbia ...
WIS
People on thyroid supplementation are being alerted to a fairly new study pointing out a connection between a high level of their thyroid hormone replacement ...
Is your thyroid medicine hurting your heart? - WTOC-TV: Savannah, Beaufort, SC, News, Weather & SportsWTOC

all 4 news articles »


Zero Stock Medicine in Gaza Threatens Cancer Patients' Lives
ReliefWeb
“Many procedures cannot be delivered with different medicines missing”, said Dr. Mohammed Abu Silmiya, director of Abdulaziz Al-Rantisi Hospital for children, which hosts a unit for cancer patients. “Colon and lung cancer as well as lymphoma patients ...

and more »


Chicago Daily Herald

Northwestern Medicine Delnor Hospital named among 'Best Hospitals' by US News & World Report
Chicago Daily Herald
"U.S. News Best Hospitals rankings of Northwestern Medicine is a direct reflection of our relentless pursuit of better medicine," said Dean M. Harrison, President and Chief Executive Officer, Northwestern Memorial HealthCare. "As Chicago's premier ...
WVU Medicine JW Ruby Memorial Hospital receives three national US News & World Report rankingsWVU Medicine (press release)
Michigan Medicine No. 5 in nation in US News hospital rankingsMLive.com
Michigan Medicine hospitals ranked No. 5 in the nation by US News & World ReportUniversity of Michigan Health System News (press release)
WXYZ -PhillyVoice.com -AZ Big Media -US News Health - US News & World Report
all 190 news articles »


2018 Healthcare+ Expo Taiwan: Where Tech Meets Medicine
Watertown Public Opinion
The medical institutes will demonstrate advanced medical technologies, smart hospital designs, products, and services while bio-pharmaceutical, medical device, and genetic enterprises will provide the most current updates in precision medicine. In all ...

and more »

Google News

home | site map | Dr. Thad Thomas
© 2006